Rosen, leading investor counsel, encourages regeneron pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action - regn

New york city, ny / access newswire / january 24, 2025 / why: new york, n.y., january 24, 2025.
REGN Ratings Summary
REGN Quant Ranking